However, the level of cooperation between direct EGFR inhibition in tumor cells versus cetuximab-induced immune killing of tumor cells may depend on various parameters including isotype of the anti-EGFR mAb, level of EGFR expression on tumor cells, abundance and activity of TAMs in the TME and FcγRIIIa polymorphisms. Here, FCGR3A is linked to neoplasm.